Filippos T Filippidis1,2, Pete Driezen3, Christina N Kyriakos4,5, Paraskevi Katsaounou2,6, Ioanna Petroulia2, Charis Girvalaki5, Marcela Fu7,8,9,10, Esteve Fernández7,8,9,10, Ute Mons11, Antigona C Trofor12,13, Tibor Demjén14, Krzysztof Przewoźniak15,16,17, Witold A Zatoński15,18, Geoffrey T Fong3,19, Yannis Tountas2, Constantine I Vardavas4,5. 1. Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. 2. Center for Health Services Research, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. 3. Department of Psychology and School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada. 4. European Network for Smoking and Tobacco Prevention, Brussels, Belgium. 5. Laboratory of Toxicology, School of Medicine, University of Crete, Heraklion, Greece. 6. First ICU Evaggelismos Hospital Athens, National and Kapodistrian University of Athens, Athens, Greece. 7. Tobacco Control Unit, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Catalonia. 8. Tobacco Control Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalonia. 9. School of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, L'Hospitalet de Llobregat, Catalonia. 10. Consortium for Biomedical Research in Respiratory Diseases (CIBER of Respiratory Diseases, CIBERES), Madrid, Spain. 11. Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany. 12. University of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania. 13. Aer Pur Romania, Bucharest, Romania. 14. Smoking or Health Hungarian Foundation, Budapest, Hungary. 15. Health Promotion Foundation, Warsaw, Poland. 16. Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 17. Collegium Civitas, Warsaw, Poland. 18. European Observatory of Health Inequalities, President Stanisław Wojciechowski State University of Applied Sciences, Kalisz, Poland. 19. Ontario Institute for Cancer Research, Toronto, Canada.
Abstract
BACKGROUND: The prevalence of roll-your-own tobacco (RYO) in Europe has been increasing. The aim of this study was to investigate transitions between factory-made (FM) cigarettes and RYO in a longitudinal sample of European smokers, and their perceptions of relative harmfulness and knowledge of health effects. METHODS: We used data collected from the EUREST-PLUS ITC 6 European Country (6E) Surveys in 2016 (n = 6011 smokers) and in 2018 (n = 6027) in Germany, Greece, Hungary, Poland, Romania and Spain. A total of 3195 cohort respondents were interviewed in both years. Use of RYO and FM, knowledge of health effects of smoking as well as perceptions about RYO were assessed. We used logistic regression models to explore sociodemographic correlates of transitions from one product to the other, of perceptions and knowledge related to smoking health effects. RESULTS: Approximately 7.4% of exclusive FM smokers transitioned to RYO and 29.5% of exclusive RYO smokers transitioned to FM cigarettes from 2016 to 2018. RYO use in 2018 was more frequent among smokers of low education and income, but none of these factors were associated with transitions. Most RYO smokers perceived RYO as cheaper than FM and 21.7% of them considered RYO to be less harmful than FM. Knowledge of the health effects of smoking was not associated with type of product smoked. CONCLUSIONS: RYO is popular among European smokers; its lower cost seems to be a major factor for RYO users; reasons for transitions to and from RYO are less clear and need to be further investigated.
BACKGROUND: The prevalence of roll-your-own tobacco (RYO) in Europe has been increasing. The aim of this study was to investigate transitions between factory-made (FM) cigarettes and RYO in a longitudinal sample of European smokers, and their perceptions of relative harmfulness and knowledge of health effects. METHODS: We used data collected from the EUREST-PLUS ITC 6 European Country (6E) Surveys in 2016 (n = 6011 smokers) and in 2018 (n = 6027) in Germany, Greece, Hungary, Poland, Romania and Spain. A total of 3195 cohort respondents were interviewed in both years. Use of RYO and FM, knowledge of health effects of smoking as well as perceptions about RYO were assessed. We used logistic regression models to explore sociodemographic correlates of transitions from one product to the other, of perceptions and knowledge related to smoking health effects. RESULTS: Approximately 7.4% of exclusive FM smokers transitioned to RYO and 29.5% of exclusive RYO smokers transitioned to FM cigarettes from 2016 to 2018. RYO use in 2018 was more frequent among smokers of low education and income, but none of these factors were associated with transitions. Most RYO smokers perceived RYO as cheaper than FM and 21.7% of them considered RYO to be less harmful than FM. Knowledge of the health effects of smoking was not associated with type of product smoked. CONCLUSIONS: RYO is popular among European smokers; its lower cost seems to be a major factor for RYO users; reasons for transitions to and from RYO are less clear and need to be further investigated.
Authors: Israel T Agaku; Filippos T Filippidis; Constantine I Vardavas; Oluwakemi O Odukoya; Ayodeji J Awopegba; Olalekan A Ayo-Yusuf; Gregory N Connolly Journal: Drug Alcohol Depend Date: 2014-03-15 Impact factor: 4.492
Authors: Abraham K Brown; Gera E Nagelhout; Bas van den Putte; Marc C Willemsen; Ute Mons; Romain Guignard; Mary E Thompson Journal: Tob Control Date: 2015-06-22 Impact factor: 7.552
Authors: Mary E Thompson; Pete Driezen; Christian Boudreau; Nicolas Bécuwe; Thomas K Agar; Anne C K Quah; Witold Zatoński; Krzysztof Przewoźniak; Ute Mons; Tibor Demjén; Yannis Tountas; Antigona Trofor; Esteve Fernández; Ann McNeill; Marc Willemsen; Constantine Vardavas; Geoffrey T Fong Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Timea R Partos; Anna B Gilmore; Sara C Hitchman; Rosemary Hiscock; J Robert Branston; Ann McNeill Journal: Nicotine Tob Res Date: 2018-05-03 Impact factor: 4.244